1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global NSAIDs Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Ibuprofen 1.2.3 Naproxen 1.3 Market by Application 1.3.1 Global NSAIDs Drug Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Drugstores 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global NSAIDs Drug Market Perspective (2017-2028) 2.2 NSAIDs Drug Growth Trends by Region 2.2.1 NSAIDs Drug Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 NSAIDs Drug Historic Market Size by Region (2017-2022) 2.2.3 NSAIDs Drug Forecasted Market Size by Region (2023-2028) 2.3 NSAIDs Drug Market Dynamics 2.3.1 NSAIDs Drug Industry Trends 2.3.2 NSAIDs Drug Market Drivers 2.3.3 NSAIDs Drug Market Challenges 2.3.4 NSAIDs Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top NSAIDs Drug Players by Revenue 3.1.1 Global Top NSAIDs Drug Players by Revenue (2017-2022) 3.1.2 Global NSAIDs Drug Revenue Market Share by Players (2017-2022) 3.2 Global NSAIDs Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by NSAIDs Drug Revenue 3.4 Global NSAIDs Drug Market Concentration Ratio 3.4.1 Global NSAIDs Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by NSAIDs Drug Revenue in 2021 3.5 NSAIDs Drug Key Players Head office and Area Served 3.6 Key Players NSAIDs Drug Product Solution and Service 3.7 Date of Enter into NSAIDs Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 NSAIDs Drug Breakdown Data by Type 4.1 Global NSAIDs Drug Historic Market Size by Type (2017-2022) 4.2 Global NSAIDs Drug Forecasted Market Size by Type (2023-2028) 5 NSAIDs Drug Breakdown Data by Application 5.1 Global NSAIDs Drug Historic Market Size by Application (2017-2022) 5.2 Global NSAIDs Drug Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America NSAIDs Drug Market Size (2017-2028) 6.2 North America NSAIDs Drug Market Size by Country (2017-2022) 6.3 North America NSAIDs Drug Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe NSAIDs Drug Market Size (2017-2028) 7.2 Europe NSAIDs Drug Market Size by Country (2017-2022) 7.3 Europe NSAIDs Drug Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific NSAIDs Drug Market Size (2017-2028) 8.2 Asia-Pacific NSAIDs Drug Market Size by Country (2017-2022) 8.3 Asia-Pacific NSAIDs Drug Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America NSAIDs Drug Market Size (2017-2028) 9.2 Latin America NSAIDs Drug Market Size by Country (2017-2022) 9.3 Latin America NSAIDs Drug Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa NSAIDs Drug Market Size (2017-2028) 10.2 Middle East & Africa NSAIDs Drug Market Size by Country (2017-2022) 10.3 Middle East & Africa NSAIDs Drug Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Detail 11.1.2 Pfizer Business Overview 11.1.3 Pfizer NSAIDs Drug Introduction 11.1.4 Pfizer Revenue in NSAIDs Drug Business (2017-2022) 11.1.5 Pfizer Recent Development 11.2 GSK 11.2.1 GSK Company Detail 11.2.2 GSK Business Overview 11.2.3 GSK NSAIDs Drug Introduction 11.2.4 GSK Revenue in NSAIDs Drug Business (2017-2022) 11.2.5 GSK Recent Development 11.3 Grunenthal 11.3.1 Grunenthal Company Detail 11.3.2 Grunenthal Business Overview 11.3.3 Grunenthal NSAIDs Drug Introduction 11.3.4 Grunenthal Revenue in NSAIDs Drug Business (2017-2022) 11.3.5 Grunenthal Recent Development 11.4 Bayer 11.4.1 Bayer Company Detail 11.4.2 Bayer Business Overview 11.4.3 Bayer NSAIDs Drug Introduction 11.4.4 Bayer Revenue in NSAIDs Drug Business (2017-2022) 11.4.5 Bayer Recent Development 11.5 Sanofi 11.5.1 Sanofi Company Detail 11.5.2 Sanofi Business Overview 11.5.3 Sanofi NSAIDs Drug Introduction 11.5.4 Sanofi Revenue in NSAIDs Drug Business (2017-2022) 11.5.5 Sanofi Recent Development 11.6 Eli Lilly 11.6.1 Eli Lilly Company Detail 11.6.2 Eli Lilly Business Overview 11.6.3 Eli Lilly NSAIDs Drug Introduction 11.6.4 Eli Lilly Revenue in NSAIDs Drug Business (2017-2022) 11.6.5 Eli Lilly Recent Development 11.7 AstraZeneca 11.7.1 AstraZeneca Company Detail 11.7.2 AstraZeneca Business Overview 11.7.3 AstraZeneca NSAIDs Drug Introduction 11.7.4 AstraZeneca Revenue in NSAIDs Drug Business (2017-2022) 11.7.5 AstraZeneca Recent Development 11.8 Endo 11.8.1 Endo Company Detail 11.8.2 Endo Business Overview 11.8.3 Endo NSAIDs Drug Introduction 11.8.4 Endo Revenue in NSAIDs Drug Business (2017-2022) 11.8.5 Endo Recent Development 11.9 Merck 11.9.1 Merck Company Detail 11.9.2 Merck Business Overview 11.9.3 Merck NSAIDs Drug Introduction 11.9.4 Merck Revenue in NSAIDs Drug Business (2017-2022) 11.9.5 Merck Recent Development 11.10 Depomed 11.10.1 Depomed Company Detail 11.10.2 Depomed Business Overview 11.10.3 Depomed NSAIDs Drug Introduction 11.10.4 Depomed Revenue in NSAIDs Drug Business (2017-2022) 11.10.5 Depomed Recent Development 11.11 Yunnan Baiyao 11.11.1 Yunnan Baiyao Company Detail 11.11.2 Yunnan Baiyao Business Overview 11.11.3 Yunnan Baiyao NSAIDs Drug Introduction 11.11.4 Yunnan Baiyao Revenue in NSAIDs Drug Business (2017-2022) 11.11.5 Yunnan Baiyao Recent Development 11.12 Teva 11.12.1 Teva Company Detail 11.12.2 Teva Business Overview 11.12.3 Teva NSAIDs Drug Introduction 11.12.4 Teva Revenue in NSAIDs Drug Business (2017-2022) 11.12.5 Teva Recent Development 11.13 J&J 11.13.1 J&J Company Detail 11.13.2 J&J Business Overview 11.13.3 J&J NSAIDs Drug Introduction 11.13.4 J&J Revenue in NSAIDs Drug Business (2017-2022) 11.13.5 J&J Recent Development 11.14 Allergan 11.14.1 Allergan Company Detail 11.14.2 Allergan Business Overview 11.14.3 Allergan NSAIDs Drug Introduction 11.14.4 Allergan Revenue in NSAIDs Drug Business (2017-2022) 11.14.5 Allergan Recent Development 11.15 Purdue 11.15.1 Purdue Company Detail 11.15.2 Purdue Business Overview 11.15.3 Purdue NSAIDs Drug Introduction 11.15.4 Purdue Revenue in NSAIDs Drug Business (2017-2022) 11.15.5 Purdue Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global NSAIDs Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Ibuprofen Table 3. Key Players of Naproxen Table 4. Global NSAIDs Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global NSAIDs Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global NSAIDs Drug Market Size by Region (2017-2022) & (US$ Million) Table 7. Global NSAIDs Drug Market Share by Region (2017-2022) Table 8. Global NSAIDs Drug Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global NSAIDs Drug Market Share by Region (2023-2028) Table 10. NSAIDs Drug Market Trends Table 11. NSAIDs Drug Market Drivers Table 12. NSAIDs Drug Market Challenges Table 13. NSAIDs Drug Market Restraints Table 14. Global NSAIDs Drug Revenue by Players (2017-2022) & (US$ Million) Table 15. Global NSAIDs Drug Market Share by Players (2017-2022) Table 16. Global Top NSAIDs Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2021) Table 17. Ranking of Global Top NSAIDs Drug Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by NSAIDs Drug Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players NSAIDs Drug Product Solution and Service Table 21. Date of Enter into NSAIDs Drug Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global NSAIDs Drug Market Size by Type (2017-2022) & (US$ Million) Table 24. Global NSAIDs Drug Revenue Market Share by Type (2017-2022) Table 25. Global NSAIDs Drug Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global NSAIDs Drug Revenue Market Share by Type (2023-2028) Table 27. Global NSAIDs Drug Market Size by Application (2017-2022) & (US$ Million) Table 28. Global NSAIDs Drug Revenue Market Share by Application (2017-2022) Table 29. Global NSAIDs Drug Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global NSAIDs Drug Revenue Market Share by Application (2023-2028) Table 31. North America NSAIDs Drug Market Size by Country (2017-2022) & (US$ Million) Table 32. North America NSAIDs Drug Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe NSAIDs Drug Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe NSAIDs Drug Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific NSAIDs Drug Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific NSAIDs Drug Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America NSAIDs Drug Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America NSAIDs Drug Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa NSAIDs Drug Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa NSAIDs Drug Market Size by Country (2023-2028) & (US$ Million) Table 41. Pfizer Company Detail Table 42. Pfizer Business Overview Table 43. Pfizer NSAIDs Drug Product Table 44. Pfizer Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 45. Pfizer Recent Development Table 46. GSK Company Detail Table 47. GSK Business Overview Table 48. GSK NSAIDs Drug Product Table 49. GSK Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 50. GSK Recent Development Table 51. Grunenthal Company Detail Table 52. Grunenthal Business Overview Table 53. Grunenthal NSAIDs Drug Product Table 54. Grunenthal Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 55. Grunenthal Recent Development Table 56. Bayer Company Detail Table 57. Bayer Business Overview Table 58. Bayer NSAIDs Drug Product Table 59. Bayer Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 60. Bayer Recent Development Table 61. Sanofi Company Detail Table 62. Sanofi Business Overview Table 63. Sanofi NSAIDs Drug Product Table 64. Sanofi Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 65. Sanofi Recent Development Table 66. Eli Lilly Company Detail Table 67. Eli Lilly Business Overview Table 68. Eli Lilly NSAIDs Drug Product Table 69. Eli Lilly Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 70. Eli Lilly Recent Development Table 71. AstraZeneca Company Detail Table 72. AstraZeneca Business Overview Table 73. AstraZeneca NSAIDs Drug Product Table 74. AstraZeneca Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 75. AstraZeneca Recent Development Table 76. Endo Company Detail Table 77. Endo Business Overview Table 78. Endo NSAIDs Drug Product Table 79. Endo Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 80. Endo Recent Development Table 81. Merck Company Detail Table 82. Merck Business Overview Table 83. Merck NSAIDs Drug Product Table 84. Merck Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 85. Merck Recent Development Table 86. Depomed Company Detail Table 87. Depomed Business Overview Table 88. Depomed NSAIDs Drug Product Table 89. Depomed Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 90. Depomed Recent Development Table 91. Yunnan Baiyao Company Detail Table 92. Yunnan Baiyao Business Overview Table 93. Yunnan Baiyao NSAIDs DrugProduct Table 94. Yunnan Baiyao Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 95. Yunnan Baiyao Recent Development Table 96. Teva Company Detail Table 97. Teva Business Overview Table 98. Teva NSAIDs DrugProduct Table 99. Teva Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 100. Teva Recent Development Table 101. J&J Company Detail Table 102. J&J Business Overview Table 103. J&J NSAIDs DrugProduct Table 104. J&J Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 105. J&J Recent Development Table 106. Allergan Company Detail Table 107. Allergan Business Overview Table 108. Allergan NSAIDs DrugProduct Table 109. Allergan Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 110. Allergan Recent Development Table 111. Purdue Company Detail Table 112. Purdue Business Overview Table 113. Purdue NSAIDs DrugProduct Table 114. Purdue Revenue in NSAIDs Drug Business (2017-2022) & (US$ Million) Table 115. Purdue Recent Development Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Global NSAIDs Drug Market Share by Type: 2021 VS 2028 Figure 2. Ibuprofen Features Figure 3. Naproxen Features Figure 4. Global NSAIDs Drug Market Share by Application in 2021 & 2028 Figure 5. Hospitals Case Studies Figure 6. Clinics Case Studies Figure 7. Drugstores Case Studies Figure 8. NSAIDs Drug Report Years Considered Figure 9. Global NSAIDs Drug Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global NSAIDs Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global NSAIDs Drug Market Share by Region: 2021 VS 2028 Figure 12. Global NSAIDs Drug Market Share by Players in 2021 Figure 13. Global Top NSAIDs Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2021) Figure 14. The Top 10 and 5 Players Market Share by NSAIDs Drug Revenue in 2021 Figure 15. North America NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America NSAIDs Drug Market Share by Country (2017-2028) Figure 17. United States NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe NSAIDs Drug Market Share by Country (2017-2028) Figure 21. Germany NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific NSAIDs Drug Market Share by Region (2017-2028) Figure 29. China NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America NSAIDs Drug Market Share by Country (2017-2028) Figure 37. Mexico NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa NSAIDs Drug Market Share by Country (2017-2028) Figure 41. Turkey NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia NSAIDs Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Pfizer Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 44. GSK Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 45. Grunenthal Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 46. Bayer Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 47. Sanofi Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 48. Eli Lilly Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 49. AstraZeneca Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 50. Endo Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 51. Merck Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 52. Depomed Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 53. Yunnan Baiyao Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 54. Teva Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 55. J&J Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 56. Allergan Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 57. Purdue Revenue Growth Rate in NSAIDs Drug Business (2017-2022) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Pfizer GSK Grunenthal Bayer Sanofi Eli Lilly AstraZeneca Endo Merck Depomed Yunnan Baiyao Teva J&J Allergan Purdue